Location History:
- Scotch Plains, NJ (US) (1977 - 1978)
- Plainfield, NJ (US) (1976 - 1981)
Company Filing History:
Years Active: 1976-1981
Title: Innovations of Peter Kulsa in Anthelmintic Agents
Introduction
Peter Kulsa is a notable inventor based in Plainfield, NJ (US), recognized for his contributions to the field of medicinal chemistry. He holds a total of 11 patents, focusing primarily on compounds that serve as effective anthelmintic agents. His work has significant implications for the treatment of helminthic infections.
Latest Patents
Among his latest patents, Kulsa has developed 3-Substituted imidazo [1,2-A] pyridines. These compounds feature a carbamate group in the 2-position and a phenylthio or phenylsulfinyl group in the 6-position, with various substituents at the 3-position, including halogen and substituted aminomethyl. These compounds are recognized for their activity as anthelmintic agents. Additionally, he has worked on certain novel substituted imidazo [1,2-a] pyridines that possess a substituted amino group at the 2- or 3-position, which are also effective against helminthic infections. The preparation of these compounds involves the use of appropriate substituted 2-aminopyridine precursors.
Career Highlights
Peter Kulsa is currently employed at Merck & Company, Inc., where he continues to innovate in the field of pharmaceutical development. His research has led to significant advancements in the treatment of parasitic infections, showcasing his dedication to improving public health through scientific discovery.
Collaborations
Throughout his career, Kulsa has collaborated with esteemed colleagues, including Helmut H Mrozik and Richard J Bochis. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.
Conclusion
Peter Kulsa's contributions to the field of medicinal chemistry, particularly in the development of anthelmintic agents, highlight his role as a significant inventor. His innovative work continues to impact the treatment of helminthic infections, showcasing the importance of research in improving health outcomes.